BURST
Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.
(Image credit: Scott Olson)
Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding
NPR
4m read
Related stories
Dozens of state laws take aim at food dyes, amid a wave support for MAHA
NPR
4m read
A creek with atomic waste from WWII is linked to increased cancer risk
NPR
5m read
She's trying to open a birth center near a maternity desert. It's not easy
NPR
7m read
An FDA panel spread misinformation about SSRI use in pregnancy, alarming doctors
NPR
6m read
In a first, the Senate confirms a new CDC director
NPR
6m read
Is Medicaid rife with fraudsters? One man explains why he breaks a rule
NPR
7m read
Warning labels on menopause treatments 'scare women', doctors tell FDA
NPR
6m read
Do 'work requirements' in Medicaid work? Georgia's been trying it for two years
NPR
9m read
How a friend's overdose drove a leading addiction scientist to look for answers
NPR
9m read
How a third parent's DNA can prevent an inherited disease
NPR
7m read
The (artificial intelligence) therapist can see you now
NPR
4m read
Trump voters wanted lower medical bills. But for millions, bills are about to go up
NPR
6m read
Senators introduce resolution supporting prevention task force RFK Jr. may disband
NPR
3m read
Even megastars like Venus Williams get the health insurance blues
NPR
5m read